Sabra Health Care REIT, Inc.
NASDAQ:SBRAREIT - Healthcare Facilities
-$0.11 today
- Market cap
- $5.40B
- Beta
- 0.63
- P/E (TTM)
- 29.0
- EPS (TTM)
- $0.62
- Dividend yield
- 6.69%
Volume 2.42M
Average 2.46M
SBRA Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Sabra Health Care REIT, Inc.NASDAQ: SBRA
Financing Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Financing cash flow turns negative
Q2 FY2026 financing cash flow was -$57.36M, compared with $36.73M a year earlier. Trailing-twelve-month financing cash flow was $100.01M.
Context
- Financing cash flow amounted to 5.3% of revenue in FY2025, down 20.6 pp from a year earlier.
- Financing cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly financing cash flow holds near -$57.36M or moves back toward the trailing-twelve-month quarterly average of $25M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 40.76M USD
- Year-over-year change
- +122.4%
- 4-year CAGR
- +7.8%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 40.76M | +122.4% |
| FY2024 | 2024-12-31 | (181.56M) | +55.7% |
| FY2023 | 2023-12-31 | (410.3M) | -153.7% |
| FY2022 | 2022-12-31 | (161.71M) | -636.5% |
| FY2021 | 2021-12-31 | 30.14M | — |
Financing Cash Flow vs competitors
How SBRA compares with its peers on the latest reported figures
- SBRA's LTM Jun 2026 financing cash flow of $100.01M is the 7th largest of the 11 companies compared; the peer median is $40.11M.
- Its year-over-year change of +155.7% is the 4th highest of 9, against a peer median of -1.6%.
- Financing cash flow amounts to 11.6% of revenue for SBRA, versus a peer median of 27.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $4.37B | -42.2% | +48.3% | 31.9% | |
| LTM Sep 2026 | $2.19B | +38.9% | — | 355.0% | |
| LTM Jun 2026 | $1.66B | -321.1% | +2.0% | 128.8% | |
| LTM Sep 2026 | $1.55B | +437.3% | — | 69.3% | |
| LTM Sep 2026 | $621.81M | +1029.4% | — | 23.3% | |
| LTM Sep 2026 | $164.96M | -307.8% | — | 36.1% | |
| LTM Jun 2026 | $100.01M | +155.7% | — | 11.6% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $66.67M | -82.3% | — | 6.5% |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $43.35M | +6902.6% | — | 12.7% |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | $42.4M | — | — | 12.4% |
| FY2025 | $37.83M | — | — | 4.9% | |
| Peer median (excluding SBRA) | $40.11M | -1.6% | +25.1% | 27.6% | |
Competitors are the stored peer set for SBRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (113.26M) | (77.61M) | 13.76M | 126.71M | 155.51M |
| Depreciation & Amortization | 178.99M | 187.78M | 183.09M | 169.62M | 187M |
| Deferred Income Tax | 227.84M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 7.91M | 7.45M | 7.92M | 8.99M | 11.36M |
| Change in Working Capital | 22.7M | (19.69M) | (2.73M) | (22.55M) | (9.85M) |
| Accounts Receivables | 8.22M | (6.44M) | (11.08M) | (15.46M) | (11.45M) |
| Inventory | (8.22M) | 0 | 11.08M | 0 | 0 |
| Accounts Payables | 14.48M | 0 | 8.34M | (7.09M) | 1.6M |
| Other Working Capital | 8.22M | (13.25M) | (11.08M) | 0 | 0 |
| Other Non-Cash Items | 32.2M | 217.8M | 98.55M | 27.77M | 4.6M |
| Operating Cash Flow | 356.39M | 315.73M | 300.57M | 310.54M | 348.61M |
| Capital Expenditures | (33.61M) | 0 | 0 | 0 | 0 |
| Acquisitions (Net) | (7.77M) | (142.91M) | (5.24M) | (1.26M) | (1.24M) |
| Purchases of Investments | (9.06M) | (8.02M) | (11.02M) | (2.83M) | (9K) |
| Sales of Investments | 1.29M | 5.38M | 5.46M | 5.94M | 7M |
| Other Investing Activities | (287.05M) | (70.69M) | 113.93M | (110.86M) | (383.71M) |
| Investing Cash Flow | (336.2M) | (216.25M) | 103.13M | (109M) | (377.96M) |
| Debt Repayment | 23.86M | 122.78M | (94.13M) | 12.56M | 107.72M |
| Common Stock Issued | 308.71M | 0 | 0 | 86.12M | 227.78M |
| Common Stock Repurchased | 0 | (4.81M) | (2.68M) | 0 | 0 |
| Dividends Paid | (262.92M) | (277.16M) | (277.45M) | (280.15M) | (289.5M) |
| Other Financing Activities | (39.51M) | (2.52M) | (36.04M) | (94K) | (5.24M) |
| Financing Cash Flow | 30.14M | (161.71M) | (410.3M) | (181.56M) | 40.76M |
| Effect of Forex Changes | 29K | 268K | (614K) | (359K) | 391K |
| Net Change in Cash | 50.36M | (61.95M) | (7.21M) | 19.62M | 11.8M |
| Free Cash Flow | 322.78M | 315.73M | 300.57M | 310.54M | 348.61M |
Sabra Health Care REIT, Inc.
NASDAQ:SBRA
Intrinsic Alpha fair value
Locked
Current Price
$20.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.